Stocktoria

20/20 Biolabs, Inc. AIDX

Nasdaq · stock · Services-Testing Laboratories · website · IPO 2021-09-08 · LEI

20/20 Biolabs, Inc. statistics & valuation

Market cap$7.3M
P / S3.6×
Net margin-182.8%
Return on capital-199%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-316.80% -182.80% 20242025
Gross margin (%)
20.60% 29.60% 20242025
Operating margin (%)
-324.00% -162.90% 20242025
Return on equity (%)
-368.80% 20242025
Shares outstanding
4.8M 5.4M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-154.90% -90.40% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$1.16 -$0.76 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin29.6%20.6%
Operating margin-162.9%-324.0%
Net margin-182.8%-316.8%
Return on assets-90.4%-154.9%
Return on equity19447.7%-368.8%
Current ratio0.601.50

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.